Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
Go back to Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update| (NASDAQ: ACHV) | Delayed: 8.05 +0.07 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.98 | 52 Week High | $ | |||
| Open | $8.03 | 52 Week Low | $ | |||
| Day High | $8.07 | P/E | N/A | |||
| Day Low | $7.82 | EPS | $ | |||
| Volume | 1,006,735 | |||||
